Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SMi’s 16th Annual Conference

Parallel Trade

21-22 March, 2022 | Conference
-------------------------------------------------------------------------

SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The 2022 event will be more significant than ever before due to the transition period follow Brexit now also coming to an end. As such, the UK will no longer be part of the EU free market. This will mean increased medicines prices, reduced access to some specialist drugs and greater risk of supply chain shortages. In a post-Brexit environment, exhaustion of rights will cease to apply to the UK, making import and export a costly business and in a worst-case scenario could effectively kill parallel distribution.

This conference will bring together industry experts to discuss the challenges and drivers of the industry, including the EU regulatory landscape and the impact of the Brexit and the Pandemic together. The conference will also provide global insights on Parallel trade and will reflect on key takeaways for other member states.

pbaynham@smi-online.co.uk

  • Discover the impact of Covid-19 on Parallel trade as countries begin to release restrictions. How has the sector been influenced?
  • Engage in discussions on the growth within parallel trade over the past year at the only Parallel Trade specific conference within the EU.
  • Discuss the impact on UK parallel trade following Brexit, through the eyes of regulators, the pharmaceutical industry and academics
  • Develop further understanding of the rules and regulation changes over the past 12 months, Parallel Trade, where are we now?

Vice President/ Heads of/General Managers:
• International Trade and Relations
• Supply Chain Development – Brexit
• Brexit Implementation
• Market Access
• Supply Chain Manager
• Parallel trade reporting
• Regulatory Affairs
• IP
• Purchasing
• Policy Patent Operations
• European Affairs
• Supply and Demand
• Attorney
• Distribution

 

AbbVie; AIFA - Agenzia Italiana Del Farmaco; Amgen Europe BV; Arnold & Porter; Baker & Mckenzie; bij CyTuVax b.v. ; Bristows LLC; Covington & Burling; Daiichi Sankyo Europe GmbH; Department of Health and Social Care; EAEPC; Erasmus University Rotterdam; Europe Economics; European Alliance for Access to Safe Medicines; European Association of Euro-Pharmaceutical Companies ; Ferring Pharmaceuticals; FERRING SA; Freshfields Bruckhaus Deringer LLP; Gilead Sciences Ltd; Hollister Europe Ltd; Intellectual Property Office; IQVIA; IQVIA Commercial GmbH & Co. OHG; Key Pharmaceuticals Ltd; Kopinke; LEO Pharma; Lisman Legal Life sciences B.V.; Medac GmbH; MHRA; MSD Animal Health ; Mundipharma; Novartis Pharma AG; Novartis Pharmaceuticals UK Ltd; Novo Nordisk Bioindustrie Sa; Novo Nordisk Ltd; SoftGroupáLtd.; UEA, University of East Anglia; White & Case LLP; Wiggin LLP; Windt Le Grand Leeuwenburgh;
 

Conference programme

8:30 Registration and Coffee

9:00 Chair's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym

Christopher Stothers

Christopher Stothers, Partner, Freshfields Bruckhaus Deringer LLP
View Bio

9:10 The trading of in-vitro-medical devices

Ulf Grundmann

Ulf Grundmann, Partner, King & Spalding LLP
View Bio

• An overview of the new EU regulation on medical devices
• The additional requirements to be met by parallel traders moving forward
• Case study related to the legal case of ‘Servoprax’
• Next steps for traders and manufacturers ahead of the IVD regulation change
 

9:50 Exhaustion of IP rights and Parallel Trade

• Parallel exports from the UK to the EEA
• Actions for parallel exporters of IP-protected goods
• Actions for IP rights holders
• Consultation on the UK’s future exhaustion of IP rights regime
 

Beatriz San Martin

Beatriz San Martin, Partner, Arnold & Porter
View Bio

Shishu Chen

Shishu Chen, Partner, Arnold & Porter Kaye Scholer (UK) LLP
View Bio

10:30 Morning Coffee

11:00 Key updates, including EU case law

Peter Bogaert

Peter Bogaert, Partner, Covington & Burling LLP
View Bio

• Update on EU case law (including on safety features)
• Lessons learnt from the new veterinary medicines Regulation (applies as from January 2022)
• A general overview on the changes in regulations over the past year
• The importance of safety within parallel trade and what can be done to improve it?
 

11:40 An update on Parallel Trade in EE

Martin Slegl

Martin Slegl, General Manager Czech Republic and Slovakia, IQVIA

• Main trends to be understood
• Access to innovation
• Selected case studies about parallel trade
 

12:20 Networking Lunch

13:20 De-branding and re-branding without the consent of the IP-owner

Paul Maeyaert

Paul Maeyaert, Partner, Fencer
View Bio

• Understanding the impact of de-branding and re-branding
• Obtaining consent from an IP owner
• The impact on IP rights holders from re-branding
• How does this effect parallel trade and the import of medicines

14:00 Latest key trends of Parallel Trade within Europe, Covid, Brexit and more…

Shabnam Hanassab

Shabnam Hanassab, Engagement Manager, IQVIA

• Latest and historical overview of Parallel Trade sales trends across the EU
• The impact of Brexit and COVID-19 on parallel trade
• Exploring the key drivers of Parallel Trade across Europe and latest examples
 

14:40 Regulatory, Economic and Market Evolution of PT

Fabrizio Gianfrate

Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara and Rome
View Bio

• PT in a next unique EU HTA and assessment scenario development
• Impact and response of PT on public healthcare services
• Future scenarios of PT for manufacturer, wholesale, and pharmacists
• Possible win-win solutions
 

15:20 Afternoon Tea

15:50 Intellectual property and free movement of goods: the internal market in pharmaceuticals

Stefan Enchelmaier

Stefan Enchelmaier, Professor of European and Comparative Law, Tutor in Jurisprudence, Lincoln College

• Territoriality of National IP Rights
• Key provisions of the relevant Directives and Regulations, and their relationship with the Treaty
• Exhaustion of the rights conferred by trademarks and patents
• When parallel trade is permissible, and when it is not
 

16:30 Panel Discussion: Understanding the impact of Parallel Trade, from production to sales

• The impact on wholesalers and pharmacists
• The working relationship between wholesalers and industry
• Manufacturing requirements and how this impacts sales
• What needs to change across the industry to improve customer safety
 

Eric Noehrenberg

Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym

Fabrizio Gianfrate

Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara and Rome
View Bio

17:10 Chair's Closing Remarks and Close of Day One

Christopher Stothers

Christopher Stothers, Partner, Freshfields Bruckhaus Deringer LLP
View Bio

Eric Noehrenberg

Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym

8:30 Registration and Coffee

9:00 Chair's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym

Christopher Stothers

Christopher Stothers, Partner, Freshfields Bruckhaus Deringer LLP
View Bio

9:10 Parallel Trade post Brexit – Regulatory Insight

Jackie Mulryne

Jackie Mulryne, Partner, Arnold & Porter
View Bio

• Summary of the changes to the regulatory framework in the UK post Brexit and the position in Northern Ireland
• The effect of Brexit on UK and EU regulations, what considerations should companies be aware of?
• Overview of regulatory considerations and impact on EU case law on parallel trade in the UK
• How to ensure your business model/supply chain is fit for purpose
 

9:50 Competition Law – An Update

Wes Lepla

Wes Lepla, Senior Associate, Covington & Burling

• State of play in the EU
• Implications of Brexit
• Language in cooperation agreements
 

10:30 Morning Coffee

11:00 Parallel Trade after Brexit – from inside and outside the EEA

Martin Howe QC

Martin Howe QC, Queens Counsel, 8 New Square
View Bio

• Government consultation on Parallel Trade and Intellectual Property (govt response if available)
• Special considerations in pharmaceutical sector, inc trademark substitution
• Parallel imports and regulatory barriers – from EEA and from outside
• Parallel importation and services
 

11:40 Parallel Trade, Northern Ireland, and the UK

Robin Blaney

Robin Blaney, Covington & Burling, Covington & Burling

• Interpretation of the Northern Irish protocol
• UK approach to parallel imports (into the UK).
• Understanding the changes and challenges
• The future of parallel trade within Northern Ireland and the UK
 

12:20 Networking Lunch

13:20 Novartis – Case study: alchemizing generic medicines into branded products in parallel trade

Jeroen Muyldermans

Jeroen Muyldermans, Partner, Fencer

• Re-branding of generic versions by parallel importers into branded originator medicines is one of the hot topics currently keeping the pharmaceutical industry busy.
• Does the first affixing of the trade mark owner’s brand on the product constitute an act of use for which exhaustion does not apply, or does intra-community free movement of goods provides for a derogation to the exclusive right?
• Is re-branding justified to ensure effective market access or rather to secure an economical advantage?
• Case-law of national courts throughout the EU has been scarce and divergent
• Two preliminary referrals involving Novartis are currently pending before the CJEU (joined cases C-253/20 and C-254/20) and merit an in-depth case study.
 

14:00 Panel Discussion: Understanding the benefits of Parallel Trade

Eric Noehrenberg

Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym

• Why is parallel trade needed? What are the benefits?
• The challenges currently faced between parallel trade and industry
• What does the future look like for Parallel Trade
 

14:40 Afternoon Tea

15:10 Avoiding fake medicines by raising public awareness

Dermot Glynn

Dermot Glynn, Senior Advisor, Europe Economics

• How can pharmaceutical companies and parallel traders both ensure patients only received safe medications
• How can we improve the public understanding of active pharmaceutical ingredients
• The role of pharmacies and wholesalers in raising public awareness
• Can we really ensure that the public understand how to avoid fake medicines
 

15:50 Parallel Trade from the perspective of Dr.Max Group

Hynek Valerian

Hynek Valerian, Group Parallel Trade Manager, Dr.Max Pharmacy Chain
View Bio

• Dr.Max Group introduction
• Perspective of the pharmacy chain
• Implications for the Group’s wholesale
 

16:30 Chair's Closing Remarks and Close of Day Two

Eric Noehrenberg

Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym

Christopher Stothers

Christopher Stothers, Partner, Freshfields Bruckhaus Deringer LLP
View Bio

+

FEATURED SPEAKERS

Beatriz San Martin

Beatriz San Martin

Partner, Arnold & Porter
Christopher Stothers

Christopher Stothers

Partner, Freshfields Bruckhaus Deringer LLP
Dermot Glynn

Dermot Glynn

Senior Advisor, Europe Economics
Eric Noehrenberg

Eric Noehrenberg

Vice President and Global Head of Market Access and Goverment Affairs, Corcym
Fabrizio Gianfrate

Fabrizio Gianfrate

Professor of Health Economics, University of Ferrara and Rome
Hynek Valerian

Hynek Valerian

Group Parallel Trade Manager, Dr.Max Pharmacy Chain
Jackie Mulryne

Jackie Mulryne

Partner, Arnold & Porter
Jeroen Muyldermans

Jeroen Muyldermans

Partner, Fencer
Martin Howe QC

Martin Howe QC

Queens Counsel, 8 New Square
Martin Slegl

Martin Slegl

General Manager Czech Republic and Slovakia, IQVIA
Paul Maeyaert

Paul Maeyaert

Partner, Fencer
Peter Bogaert

Peter Bogaert

Partner, Covington & Burling LLP
Robin Blaney

Robin Blaney

Covington & Burling, Covington & Burling
Shabnam Hanassab-Braude

Shabnam Hanassab-Braude

Engagement Manager, IQVIA
Shishu Chen

Shishu Chen

Partner, Arnold & Porter Kaye Scholer (UK) LLP
Stefan Enchelmaier

Stefan Enchelmaier

Professor of European and Comparative Law, Tutor in Jurisprudence, Lincoln College
Tushar Patel

Tushar Patel

Technical Director, Key Pharmaceuticals Ltd
Ulf Grundmann

Ulf Grundmann

Partner, King & Spalding LLP

Beatriz San Martin

Partner, Arnold & Porter
Beatriz San Martin

Beatriz focuses her intellectual property practice on the life sciences sector and innovative technologies, with niche SPC experience. She effectively manages and resolves disputes, assists clients on challenging technical legal issues and provides strategic IP advice.

Her disputes practice is varied with significant and high-profile experience handling cases before the UK Courts and the Court of Justice of the European Union, as well as assisting in multinational arbitrations. Besides her patent and SPC experience, she has also handled disputes and matters covering the full breadth of intellectual property rights including trademarks, database rights, copyright, design rights and trade secrets.
 

Christopher Stothers

Partner, Freshfields Bruckhaus Deringer LLP
Christopher Stothers

Christopher is a recognized expert in parallel trade, with a particular focus on the pharmaceutical sector - his 2007 textbook, “Parallel Trade in Europe: Intellectual Property, Competition and Regulatory Law,” has been cited by the UK Supreme Court. Christopher is also an experienced litigator on cross-border patent disputes, other types of intellectual property, antitrust, pharmaceutical regulation, EU law and commercial disputes. He has taken cases before the First Tier Tribunal, the Upper Tribunal, the Patents County Court, the High Court, the Court of Appeal, the House of Lords, the Supreme Court, the European Patent Office, and the European Court of Justice.

Dermot Glynn

Senior Advisor, Europe Economics
Dermot Glynn

Eric Noehrenberg

Vice President and Global Head of Market Access and Goverment Affairs, Corcym
Eric Noehrenberg

Fabrizio Gianfrate

Professor of Health Economics, University of Ferrara and Rome
Fabrizio Gianfrate

Bio of Fabrizio Gianfrate
PhD in Health Economics (1985), Masters in HE at Stockolm, York and Rome
-Current positions
Full Professor of Health Economics and Outcome Research
Market Access consultant
-Past roles
Ex payer (AIFA, Regions and Hospitals), formerly director at Ministry of Health,
Responsible of WHO Collaborative Centers.
In the past director of pharmaceutical Companies Foundations, Editorial director of
pharma magazines
Winner of the 2004 Award for Culture of Ministry of University
-Other
Actually board member of scientific societies and associations.
Author of more than 700 publications and 7 books on pharmaceutical economics and
policies

Hynek Valerian

Group Parallel Trade Manager, Dr.Max Pharmacy Chain
Hynek Valerian

Hynek has spent more than 20 years in pharmaceutical and consumer health market research focusing on the Czech and Slovak markets. In 2020 he joined Dr.Max Group, a leading European pharmacy chain, as the Group Parallel Trade Manager.
Hynek holds MSc degree in Biophysics from Charles University in Prague, PhD degree in Physical Chemistry from the Academy of Sciences of the Czech Republic and MBA degree from Sheffield Hallam University.
 

Jackie Mulryne

Partner, Arnold & Porter
Jackie Mulryne

Jackie Mulryne advises clients in the life sciences and MedTech sectors, and has a broad practice providing regulatory compliance and public policy advice. She advises on UK and EU law, and has experience with a range of regulatory issues that arise throughout the product lifecycle. She regularly develops strategies to help bring innovative products to market, and has assisted a number of client in developing and implementing cross-border regulatory and compliance programmes.
Jackie also advises on contentious disputes in the sector, and has extensive experience in public and administrative law challenges to the decisions of regulatory bodies in the UK and EU.
 

Jeroen Muyldermans

Partner, Fencer
Jeroen Muyldermans

Martin Howe QC

Queens Counsel, 8 New Square
Martin Howe QC

Martin Howe QC is one of the leading practitioners in the field of parallel imports and their relationship to intellectual property law and regulatory law. Among the key cases in which he has appeared as counsel are C-403/08 FAPL v QC Leisure/Karen Murphy (Grand Chamber, 2011) on the parallel importation and use of satellite decoder cards, and C-267 Merck v Primecrown (Full Court, 1996) on patented drugs within the EU single market and from accession states.

He is also chairman of Lawyers for Britain, formed in 2016 as the lawyers’ group supporting Leave in the referendum campaign, which continues to work on legal issues where the UK can take advantage of its freedom of action in the post Brexit global environment.
 

Martin Slegl

General Manager Czech Republic and Slovakia, IQVIA
Martin Slegl

Paul Maeyaert

Partner, Fencer
Paul Maeyaert

Paul Maeyaert is a founding partner at Fencer, an IP boutique law firm specializing in intellectual property, media & advertising, distribution as well as related practice areas. Paul’s intellectual property expertise has a particular focus on trademark, patent and copyright litigation, anti-counterfeiting, and parallel trade matters. He is a member of the Brussels bar and, over the past decades, Paul has built a vast experience as a litigator, not only before the Belgian courts, but also before the European courts.
Paul also lectures on European trademark law at the Université de Liège, as part of its LL.M program “Competition law and IP” and is a guest lecturer on advertisement law in Brussels at the VUB and the Université Saint-Louis. He also lectures at the yearly IP Summer School at Downing College, Cambridge. He is a frequent conference speaker and has authored several publications in the areas of intellectual property, distribution and advertising.
E-mail: paul.maeyaert@fencerlaw.eu

Peter Bogaert

Partner, Covington & Burling LLP
Peter Bogaert

Peter Bogaert has a broad European life sciences practice. He has detailed regulatory expertise under EU and national laws, handles legislative and other policy assignments and provides strategic advice. He also represents life sciences companies before the EU Courts in Luxembourg and in local litigation in Belgium. Peter's practice covers pharmaceuticals, biotechnology, medical devices, special foods and feed, cosmetics and other consumer products and he represents numerous innovative life sciences companies, including start-ups, as well as several industry associations.


Chambers Global notes that a client said: “He is an extremely experienced professional with broad expertise and provides sensible and well-balanced solutions." He is consistently ranked by PLC as one of the leading life sciences lawyers globally and Legal 500 EMEA and Chambers Europe note Peter's prominent regulatory pharmaceutical and environmental practice. Legal 500 EME noted that he is "a superb lawyer who is very pleasant to work with." Peter regularly writes and speaks on life sciences issues. He is a founding member of the Brussels Pharma Law Group and also served for fifteen years as Managing Partner of the firm’s Brussels office.
 

Robin Blaney

Covington & Burling, Covington & Burling
Robin Blaney

Shabnam Hanassab-Braude

Engagement Manager, IQVIA
Shabnam Hanassab-Braude

IQVIA’s expert and thought leader in European Parallel Trade dynamics, supply chain and distribution with several years of experience working in this field. Shabnam has developed in-depth expertise in pharmaceutical market dynamics and the increasing complexities of the trading environment. Shabnam is highly experienced on IQVIA’s data types, coverage and various supply chain offerings available centrally as well as locally, working with network of people within and outside organization. She has led several European supply chain consulting projects in the past few years.

Shabnam holds BSc, MSc and PhD from University of London in Pharmaceutical and Computational Chemistry.

 

Shishu Chen

Partner, Arnold & Porter Kaye Scholer (UK) LLP
Shishu Chen

Shishu Chen focuses her practice on intellectual property matters. Her experience includes advising clients on enforcing and defending patents, trade marks, designs, copyright and confidential information, and this has included coordinating investigations on counterfeiting activities, assisting in pre-action counseling and negotiations, acting for clients in both civil infringement litigation and criminal prosecution, representing clients in applications for site-blocking orders, and initiating and defending trade mark opposition proceedings.
Ms. Chen also advises clients on IP-related issues arising from commercial transactions, and assists clients with the drafting of agreements for licensing, contract manufacturing, franchising, joint development, and supply of goods and services. She has experience in conducting full suite IP audits to support IP valuations, and regularly assists with IP due diligence exercises.
Ms. Chen acts for clients across a range of sectors and industries, including pharmaceutical, life sciences, fintech, education, food & nutrition and retail. She is qualified as a solicitor in England and Wales, and as an advocate and solicitor of Singapore. She is fluent in Mandarin.

 

Stefan Enchelmaier

Professor of European and Comparative Law, Tutor in Jurisprudence, Lincoln College
Stefan Enchelmaier

Tushar Patel

Technical Director, Key Pharmaceuticals Ltd
Tushar Patel

Ulf Grundmann

Partner, King & Spalding LLP
Ulf Grundmann

Ulf Grundmann is partner in King & Spalding’s FDA & Life Sciences practice group and is located in Frankfurt, Germany. With more than 25 years of experience, his practice focuses on the medical device, pharmaceutical, cosmetics and food industries. Ulf advises clients in all areas of EU regulatory, unfair competition and compliance law and represents clients before national and European authorities. Ulf is an experienced appellate litigator well known for representing his clients in litigation cases before German and European courts, including the General Court and the Court of Justice of the European Union.

Supporters

Workshops

Parallel Trade, let’s talk details
Workshop

Parallel Trade, let’s talk details

Venue To Be Confirmed
23rd March 2022
London, United Kingdom

The Case Law of Parallel Imports
Workshop

The Case Law of Parallel Imports

Venue To Be Confirmed
23rd March 2022
London, United Kingdom

VENUE

Venue To Be Confirmed

London, United Kingdom

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM

Conference Co-Chair Letter

Download

Chair & Speaker Biographies

Download

Workshop B Agenda

Download

Workshop A Agenda

Download

Past Attendees

Download

Parallel Trade Brochure 2022

Download

Past Presentation - Peter Bogaert, Covington

Download

Past Presentation - Dr. Eric Noehrenberg, NIPC

Download

Past Presentation - Jackie Mulryne, Arnold & Porter

Download

Past Presentation - Dr Christopher Stothers, Freshfields Bruckhaus Deringer LLP

Download

Media Partners


Pharmiweb

Supporters
http://www.pharmiweb.com

Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


Pharmaceutical Technology

Supporters
http://www.pharmaceutical-technology.com

Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


Farmavita

Supporters
https://farmavitar.com

FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


PharmaVOICE

Supporters
http://www.pharmavoice.com

PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


ASD MEDIA

Supporters
http://www.asd-network.com

Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
  • Be informed on the latest market developments; www.asd-network.com
  • Find the latest business news; www.asd-network.com
  • Find the upcoming events; www.asd-network.com
  • Find companies and organizations; www.asdsource.com
  • Distribute news globally. www.asdwire.com
The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

For more detailed information please contact with: ASD MEDIA
Stefan.koopman@asdmedia.nl


World Pharma Today

Supporters
http://www.worldpharmatoday.com



Technology Networks

Supporters
http://go.technologynetworks.com/subscribe-to-newsletters

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


Pharma Journalist

Supporters
http://www.pharmajournalist.com

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


Pharmaceutical Outsourcing

Supporters
http://www.pharmoutsourcing.com

Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


Gate2Biotech

Supporters
http://www.gate2biotech.com

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


Drug Discovery Today

Supporters
http://www.drugdiscoverytoday.com/

Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


Biocompare

Supporters
http://www.biocompare.com

Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


American Pharmaceutical Review

Supporters
http://www.americanpharmaceuticalreview.com

Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


Pharmacircle

Supporters
http://www.pharmacircle.com

PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Venue To Be Confirmed

London
United Kingdom

Venue To Be Confirmed

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out